SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company (Nasdaq:LJPC) announced today that its financial statements for the fiscal year ended December 31, 2007, included in the Company's Annual Report on Form 10-K filed on March 17, 2008, contain a going concern qualification to the audit opinion from its independent registered public accounting firm, Ernst & Young, LLP. The Company intends to raise additional capital in fiscal 2008 to support its operations.
